Sign in

You're signed outSign in or to get full access.

Timothy Sopko

Timothy Sopko

Chief Executive Officer at TAYLOR DEVICES
CEO
Executive
Board

About Timothy Sopko

Timothy J. Sopko, 59, is Chief Executive Officer of Taylor Devices (since April 2019) and a director since 2020. He holds a Mechanical Engineering degree from SUNY Buffalo and is an author/co-author on several U.S. patents . Under his tenure, Taylor posted record FY2025 sales of $46.3M and net income of $9.4M (20.3% net margin), following a record FY2024, with management citing Aerospace/Defense and Industrial strength offsetting Structural headwinds and a starting FY2026 order backlog of $27.1M . Multi‑year pay‑versus‑performance disclosures show strong TSR over the 2022–2024 period and sustained profitability: the company’s $100 TSR measure rose from $78 (FY2022) to $526 (FY2024) before settling at $393 (FY2025), with net income of $2.24M (FY2022), $6.29M (FY2023), $9.00M (FY2024), and $9.41M (FY2025) .

Past Roles

OrganizationRoleYearsStrategic impact
Carleton Technologies (d.b.a. Cobham Mission Systems)VP & GM; GM; Director of Engineering & Programs; Director of Engineering; Director of Business DevelopmentPre-2019Grew annual sales from ~$110M to >$200M under Sopko’s leadership as VP & GM .
Comprehensive Technical Solutions Inc.Co‑founder1997–2019 (co‑founded after 1988–1997 in industry)Product design engineering services; supported internally funded product portfolio .

External Roles

OrganizationRoleYearsNotes
SUNY Buffalo Mechanical & Aerospace Dean’s Advisory BoardMember>10 years (historical)Academic/industry advisory engagement .

Fixed Compensation

MetricFY 2024FY 2025
Base salary (paid)$300,000 $320,000
Employment Agreement base salary (in effect)$320,000 (dated Aug 9, 2021; proxy updated to $320k) $329,600 (updated)
Cash bonus (actual)$307,863 $203,000
All other comp (incl. car allowance, 401k match)$26,608 $28,716
Total reported comp$755,904 $631,696
Annual bonus plan designAggregate payouts capped at 15% of company net income; Compensation Committee discretion

Performance Compensation

  • Equity awards are stock options; the Company does not disclose RSUs/PSUs for NEOs in these proxies. Annual fixed-date grants occur on April 18 under option plans .
Incentive elementFY 2024FY 2025
Option award grant size7,000 options 7,000 options
Grant dateApr 18, 2024 Apr 18, 2025
Exercise price$46.99 (FMV at grant) $30.55 (FMV reference: Apr 17, 2025 close)
Reported grant-date fair value$121,433 $79,980
VestingNot explicitly stated for 2022 Plan; options shown as exercisable in outstanding table . For 2025 Plan (effective Oct 17, 2025), director options vest immediately upon grant .
Performance metricsCash bonus pool tied to Company net income (aggregate cap 15%); no individual metric weightings disclosed .

Outstanding Options (as of FY2025 year-end)

StrikeQuantity (exercisable)Expiration
$9.52505,00004/18/32
$9.85005,00004/18/30
$11.95005,00004/22/31
$19.95507,00004/18/33
$30.55007,00004/18/35
$46.99267,00004/18/34

Equity Ownership & Alignment

ItemDetail
Beneficial ownership46,000 shares (includes 36,000 unexercised options) = 1.37% of outstanding as of Aug 18, 2025 .
Shares outstanding (record date)3,147,193 as of Aug 18, 2025 .
Pledging / hedgingHedging prohibited under Insider Trading Policy; no pledging disclosed .
Ownership guidelinesNot disclosed in proxies reviewed.
Option plan supply & dilutionOptions outstanding 399,300; weighted avg exercise $22.89; WAM 6.9 yrs; 2025 Plan proposed reserve 316,200; fully diluted overhang ~11.9% rising to ~18.5% if approved .
Burn rateFY2023: 2.4%; FY2024: 2.5%; FY2025: 2.9% .

Employment Terms

TermKey provisions
AgreementEmployment Agreement (initially Aug 9, 2021; auto‑renews annually) .
Base salary in agreement$329,600 (CEO) per 2025 proxy update; eligible for performance bonus .
Severance (no‑cause or non‑renewal by Company)12 months base salary + up to 12 months COBRA premium reimbursement (if elected) .
Non‑compete12 months post‑termination in any geography where Company had sales in prior 5 years .
Change‑of‑control (cash)No separate cash multiple disclosed.
Equity on change‑of‑controlCommittee discretion: continue/assume/substitute; cash‑out for spread; or cancellation with exercise window; no automatic repricing; no guaranteed acceleration .
ClawbackCompany Recovery of Erroneously Awarded Compensation Policy applies; options subject to clawback under law/listing rules .
Indemnification & D&OD&O policy renewed Aug 23, 2025 ($54,559 premium); indemnity agreements advance expenses .

Board Governance (Sopko is a director)

  • Board service: Director since 2020; Class 2 term through 2026 . Independent Chair (John Burgess); CEO and Chair roles are separated .
  • Committees: Audit (Chair: Burgess), Compensation (Chair: Armenat), Nominating (Chair: Carey); all three members (Burgess, Armenat, Carey) are independent .
  • Board meetings and attendance: FY2025 Board met 3 times; full attendance; all directors attended 2024 annual meeting .
  • Dual-role implications: Sopko serves as CEO and director, but not as Chair; committee oversight is fully independent, mitigating CEO/Chair consolidation risk .

Director Compensation (context for board service)

ElementAmount
Quarterly retainer (Chair)$11,000 per quarter
Quarterly retainer (other non‑employee directors)$7,000 per quarter
Committee feesAudit: $2,000 per meeting; Comp/Nominating: $1,000 per meeting
Annual director option grant7,000 options (e.g., Apr 18, 2025 at $30.55; Apr 18, 2024 at $46.99)

Company Performance Context

MetricFY 2023FY 2024FY 2025
Revenues ($)$40,199,354 [GetFinancials]*$44,582,807 $46,292,725
Net Income ($)$6,287,358 $8,998,762 $9,413,136
EBITDA ($)$8,281,521 [GetFinancials]*$11,177,065 [GetFinancials]*$11,358,399 [GetFinancials]*
EBITDA Margin (%)20.60% [GetFinancials]*25.07% [GetFinancials]*24.54% [GetFinancials]*
TSR – value of $100 initial investment$198 $526 $393
Note: Values with an asterisk (*) retrieved from S&P Global.

Compensation Structure Analysis

  • Mix shift: FY2025 total comp fell 16% YoY driven by a lower cash bonus ($203k vs. $308k) despite a higher base salary ($320k vs. $300k), while option grant value also decreased ($79,980 vs. $121,433) .
  • Pay-for-performance linkage: Bonus pool is capped at 15% of company net income, aligning cash incentives with profitability but without disclosed individual metric weightings or targets .
  • Equity design: Fixed annual option grants at FMV on a pre-set date reduce timing risk; no repricing without shareholder approval; robust change‑in‑control treatment gives Board flexibility but no automatic acceleration .
  • Dilution trend: Three‑year burn rate averaged ~2.6% with proposed 2025 Plan potentially lifting overhang to ~18.5%, which could be dilutive if exercised broadly .

Risk Indicators & Red Flags

  • Hedging prohibited; no pledging disclosed (alignment positive) .
  • Option repricing prohibited without shareholder approval (governance positive) .
  • Related party transactions: None disclosed for FY2025; none disclosed for FY2024 .
  • Section 16 compliance: All filings timely in FY2025 .

Say‑on‑Pay & Shareholder Feedback

  • No say‑on‑pay voting results disclosed in the proxies reviewed (not presented in FY2024–FY2025 proxies) .

Expertise & Qualifications

  • Mechanical Engineering degree; extensive engineering, program management, and operating leadership experience across aerospace/defense and industrial markets; multiple U.S. patents; prior advisory board service at SUNY Buffalo .

Work History & Career Trajectory

CompanyRole(s)Tenure summary
Taylor Devices, Inc.CEO (since Apr 2019); Director (since 2020)Led record FY2024–FY2025 results; backlog entering FY2026 $27.1M .
Carleton Technologies/Cobham Mission SystemsMultiple leadership roles incl. VP & GMScaled revenue >$200M from ~$110M as VP & GM .
Comprehensive Technical Solutions Inc.Co‑founderProduct design firm; internal products supported .

Compensation Committee Analysis

  • Composition: Independent directors Carey, Burgess, Armenat; Chair: Armenat .
  • Process: Reviews executive pay philosophy/goals; considers company performance and peer/company history; administers stock option plans .
  • Consultant disclosure: None referenced in proxies reviewed.

Investment Implications

  • Alignment: CEO bonus pool tied to profitability and a history of record net income supports alignment; hedging bans and lack of pledging reduce misalignment risk .
  • Potential selling pressure: Material in‑the‑money option tranches with staggered expirations (2029–2035) could create episodic supply; annual fixed‑date grants institutionalize ongoing issuance .
  • Dilution watch: If shareholders approved the 2025 Stock Option Plan, overhang rises toward ~18.5%; coupled with a ~2.5–3% burn rate, this is a key input for valuation and per‑share calculus .
  • Retention/transition risk: Employment agreement provides 12‑month salary + COBRA severance and 12‑month non‑compete; no rich change‑in‑control cash multiple—adequate but not excessive, suggesting moderate retention incentives .
  • Execution track record: Record FY2024–FY2025 revenue and margins (20%+ net margin) with positive Aerospace/Defense and Industrial momentum underpin confidence; TSR has been volatile but strong over multi‑year horizons .

Sources: FY2025 and FY2024 DEF 14A proxies and company press releases; select metrics from S&P Global where marked with an asterisk.